Obdulia Martínez-García, MS | Psychiatrist.com

Original Research

Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study

April 27, 2016

Jacqueline Mayoral-van Son, Victor Ortiz-Garcia de la Foz, Obdulia Martínez-García, et al

Original Research

Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison

April 21, 2009

Benedicto Crespo-Facorro, José M. Rodríguez-Sánchez, Rocío P. Pérez-Iglesias, et al

Original Research

A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone

November 15, 2007

Rocío Pérez-Iglesias, Benedicto Crespo-Facorro, Jose Antonio Amado, et al

Original Research

A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.

October 16, 2006

Benedicto Crespo-Facorro, Rocío Pérez-Iglesias, MariLuz Ramirez-Bonilla, et al

Original Research

Attenuation of Antipsychotic-Induced Weight Gain With Early Behavioral Intervention in Drug-Naive First-Episode Psychosis Patients: A Randomized Controlled Trial

August 15, 2006

Mario Álvarez-Jiménez, Cesar González-Blanch, Jose Luis Vázquez-Barquero, et al